Sun Pharma Advanced Research Company Q1FY22 loss at Rs. 61.37 Cr
Chemical

Sun Pharma Advanced Research Company Q1FY22 loss at Rs. 61.37 Cr

The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.

  • By ICN Bureau | July 27, 2021

Sun Pharma Advanced Research Company has reported total income of Rs.22.79 crores during the period ended June 30, 2021 as compared to Rs.28.39 crores during the period ended March 31, 2021.

The company reported total income of Rs.186.11 crores during the period ended June 30, 2020.

Sun Pharma Advanced Research Company has posted net loss of Rs.(61.37) crores for the period ended June 30, 2021 as against net loss of Rs.(56.72) crores for the period ended March 31, 2021.

The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.

Register Now to Attend Chem Connect 2025 on August 21th 2025, Novotel Mumbai International Airport

Upcoming Conferences

Chem Connect 2025

August 21, 2025

Other Related stories

Startups

Petrochemical

Energy

Digitization